高同型半胱氨酸血症作为颅内动脉瘤的危险因素:一项病例对照研究
在巴西一家血管神经外科单位于2016至2017年开展的病例对照研究中,纳入142例既往颅内动脉瘤患者与38例无动脉瘤的动静脉畸形患者作为对照。高同型半胱氨酸血症定义为同型半胱氨酸水平大于15 μmol/L,多因素校正后其与颅内动脉瘤无关联(比值比1.34,95%置信区间0.30-5.97,P=0.703)。
要点
- 病例组同型半胱氨酸中位数与对照组相似(10.5 μmol/L vs 10.7 μmol/L,P=0.450)。
- 高同型半胱氨酸血症患病率在病例组呈较高趋势(20.4% vs 7.9%,P=0.073)。
- 多因素校正后高同型半胱氨酸血症与颅内动脉瘤无关联(比值比1.34,95%置信区间0.30-5.97,P=0.703)。
核心结论
- 未发现高同型半胱氨酸血症与颅内动脉瘤之间存在关联。
研究设计与样本
- 在巴西一家血管神经外科单位于2016至2017年开展的病例对照研究,共纳入180例患者:142例既往颅内动脉瘤患者为病例组,38例既往诊断动静脉畸形且影像学评估无动脉瘤的患者为对照组。
主要发现
- 病例组年龄更大(56.3 ± 12.6岁 vs 40.9 ± 14.0岁,P < 0.001)。
- 病例组女性比例更高(76.1% vs 55.3%,P = 0.012)。
- 病例组高血压(45.1% vs 2.6%,P < 0.001)、血脂异常(60.6% vs 10.5%,P = 0.001)和吸烟(41.5% vs 0.0%,P < 0.001)比例更高。
- 病例组同型半胱氨酸中位数与对照组相似(10.5 μmol/L [8.3-14.0] vs 10.7 μmol/L [8.2-13.3],P = 0.450)。
- 病例组高同型半胱氨酸血症患病率呈较高趋势(20.4% vs 7.9%,P = 0.073)。
关键数值与推荐
- 高同型半胱氨酸血症定义为同型半胱氨酸水平大于15 μmol/L。
- 多因素模型校正年龄、性别、高血压、血脂异常和吸烟状态后,高同型半胱氨酸血症与颅内动脉瘤无关联(比值比1.34,95%置信区间0.30-5.97,P = 0.703)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Homocysteine, an amino acid derived from methionine metabolism, has gained great importance as an important risk factor for cardiovascular diseases as the result of its thrombogenic properties and endothelial injury association. However, its role in the etiology and screening of intracranial aneurysms (IAs) has not been well studied. We aimed to test the hypothesis of a positive association between hyperhomocysteinemia (HHcy) and IAs. METHODS: A case-control study was performed at a vascular neurosurgery unit in Brazil between 2016 and 2017. In total, 180 patients were included: 142 patients with previous IAs (case group) and 38 patients with a previous diagnosis of arteriovenous malformation and no aneurysms on imaging evaluation (control group). HHcy was defined as homocysteine levels greater than 15 μmol/L. Multivariate models were designed to adjust for potential confounders: age, sex, hypertension, dyslipidemia, and smoker status. RESULTS: The case group was older (56.3 ± 12.6 years vs. 40.9 ± 14.0 years, P < 0.001) and had a greater prevalence of women (76.1% vs. 55.3%, P = 0.012), as well as hypertension (45.1% vs. 2.6%, P < 0.001), dyslipidemia (60.6% vs. 10.5%, P = 0.001), and smokers (41.5% vs. 0.0%, P < 0.001). Median homocysteine in the cases was similar to the controls (10.5 μmol/L [8.3-14.0] vs. 10.7 μmol/L [8.2-13.3], respectively, P = 0.450). There was a trend toward greater HHcy prevalence in the case group (20.4% vs. 7.9%, P = 0.073). HHcy was associated with greater age, male sex, hypertension, and smoking status. After multivariate adjustment, HHcy had no association with IAs (odds ratio 1.34, 95% confidence interval 0.30-5.97, P = 0.703). CONCLUSIONS: No association was found between HHcy and IAs.
引用
- Rosi J, Morais BA, Pecorino LS, et al. Hyperhomocysteinemia as a Risk Factor for Intracranial Aneurysms: A Case-Control Study. World Neurosurg. 2018. PMID: 30053565. doi:10.1016/j.wneu.2018.07.132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。